| This article may be disseminated and shared as long as it is
retained in its entirety, including author and references.
Virtual book burning and the Lyme Disease
“Federation”
An opinion piece by author PJ Langhoff
“If they give you ruled paper, write
the other way.”[1]
One method utilized by the German Nazi party during the early part of
this century to control civilian thought processes was through literary
censorship. In April 1933, the german students association’s press and
propaganda office declared a nationwide action which included a literary
purge or cleansing by fire. The SA (Sturmabteilung, german for “storm
department” or “stormtroopers”) “brown shirts,”so named for their SA
uniform, participated in very public book burnings such as those in
Munich and Berlin that year. More than a hundred years earlier, the poet
Heinrich Heine said, “Where books are burned, human beings are destined
to be burned too.”
Seventy-five years later (as we enter 2008), we again witness what
appears to be a deliberate censorship declaration designed to control
the thought processes of the masses, this time in the arena of the Lyme
disease-afflicted. But the “books” burned aren’t necessarily made of
paper, they are also the virtual books, articles, and opinion pieces
located in cyberspace, the “new frontier” of medical politics. This
includes peer-reviewed articles, published articles in trade journals,
newspapers, research data; all the way down to the opinions of
advocates, patients and also physician organizations. The end result is
the attempted purging of an entire line of thinking about a complex,
endemic illness which has been declared off-limits by this “Federation”
to the masses; in favor of a minimized, slow-played, non-endemic, less
serious version, (with devastating consequences to thousands).
Enter a small group of powerful Infectious Disease academicians and
their supportive, grant-funding government agencies, and medical board
associates, whom I will collectively dub here (a pretend) Lyme denialist,
stormtrooper posse called the “Federation.” Please do not misquote or
misunderstand. I am merely poking fun here and not remotely suggesting
anyone referenced are Nazis, SA members, extremists, or are of any
particular nationality. But I am making a point that in the media, we
see a similar kind of censorship being played out in a very political
arena, at the hands of a select group of Infectious Disease academicians
(some of my pretend “Federation.”)
Some Federation members seem to trumpet their position that Lyme
patients and their doctors are attention-seeking hypochondriacs who are
imagining an illness which doesn’t exist. Others are attempting to
promote restrictive guidelines for the diagnosis and treatment of an
illness that at best, is poorly understood. Meanwhile, the earlier
research and materials published by members of this imaginery Federation
seems to now conflict with their most recently widely published
"denials" that the illness exists in its most serious, chronic form.
And despite very ill patients and their doctors’ attempts to illustrate
what the Federation already knows (that Lyme disease is a debilitating
illness with a chronic form when improperly treated), the Federation
appears to be working diligently in the background to silence anyone who
does not agree with its current modus operandi. This includes but is not
limited to the upcoming meeting December 18, 2007 at the Hartford, CT
Legislative Office building from 10 a.m to noon. In what can only be
described as another strategic effort on the Federation’s part, IDSA
member Durland Fish will speak at a forum on Lyme disease “prevention.”
Incidentally, no Lyme advocacy representatives have been invited to
attend, though it is admittedly a public event.
At the same location on the same date, but at 1:30 p.m., renowned
pediatric Lyme physician Dr. Charles Ray Jones will be present for his
legislative hearing regarding his licensure and accusations by the CT
medical board of “unprofessional conduct.” Some accusations included his
failure to examine two children before prescribing medications –
something that most physicians across the country in all forms of
medicine, routinely do. Those who know Dr. Jones and who are familiar
with his case, will tell you that is not what happened.
And it is no surprise that his hearing would be strategically targeted
by the Federation either. Patients and advocates see it as another
attempt by the Federation to silence anyone with an anti-Federation
viewpoint. Perhaps since they cannot burn books, they might as well burn
reputations. From the viewpoint of this imaginery Federation, perhaps
obliterating a beloved Lyme physician who did nothing wrong, by offering
their physical presence to go hand-in-hand with false accusations and
trumped up charges resulting in “discipline” is a convenient way to
“teach” other physicians not to go against the Federation’s views. How
convenient that a Federation forum will be held at the exact location,
and just an hour and a half before the very public crucifixion of a
physician servant who has dedicated his life to treating thousands of
ill children – someone who is perhaps the most beloved and important
Pediatric Lyme specialist in the country.
And the persistence of the ideology of the Federation “members,” whom in
part drafted and promote restrictive guidelines which seem to define
chronic Lyme disease out of existence, and for which they previously
acknowledged existed, is mind-boggling. At present, the IDSA Lyme
disease guidelines are under investigation by the CT Attorney General’s
office for possible anti-trust violations. This has to do with the
unilateral formation of the guidelines excluding important peer-reviewed
research, and the possibility that their structure and edict will impose
restrictions on insurance company benefits and patient treatment
options.
And patients and their physicians witness tit-for-tat publications in
intermedia arguments defending both sides of the Lyme debate – a staunch
Federation position with attempts at censorship, and a re-teaching that
Lyme disease is “hard to catch” and “easy to treat”; and the “other
side,” which includes ill patients and their physicians left with
debilitating illness barely acknowledged by the Federation, government,
insurance, and many doctors. How has this censorship come about?
Around 1975, academician, Infectious Disease Society of America member
and Rheumatologist Dr. Allen Steere and his Yale university associates
dubbed a strange illness “Lyme Disease,” so named after the town in
which the first cluster cases were identified, thanks in part to the
persistence of a housewife named Polly Murray. Over the course of a few
years, Lyme disease was defined as an illness with various stages,
including a chronic form.
In 1980, Steere and associate Malawista wrote that some patients (even
when treated soon after an EM rash), developed later manifestations, and
some patients with these manifestations never experienced a rash.[2] In
1983, Steere’s associate Barbour (et al.) wrote an article describing
Lyme as a “multisystem” disorder.[3] In 1984, Steere and Barbour wrote
an article revealing knowledge in 1955 that an EM rash could be passed
from human to human.[4] The following year Steere and associate Pachner
wrote an article about a triad of neurological symptoms of Lyme
disease.[5] The authors discussed the duration of the acute phase of the
illness lasting up to 18 months in those not receiving antibiotic
therapy. (Those studied were not followed for a more extended time.)
In 1988, Steere associate Pachner wrote an article about Bb in the
nervous system calling it the “new great imitator.”[6] He outlined
similarities between Bb and syphilis, with the ability of both organisms
to “stay alive in human tissue for years.” He also outlined the stages
of LD, including early skin disease and later disease in the brain. He
warned “the effective clinician must take special care to consider Lyme
disease primarily because of the excellent response to antibiotics early
in its course in relationship to some of the diseases it mimics.” He
labeled lyme meningitis the second stage of the disease, (including the
EM rash). He suggested that most patients have very mild symptoms, and
called it “likely that a large percentage of patients go undiagnosed and
untreated.” He further elaborated that “the frequency of progression to
third-stage disease is unknown but may be quite high”, inferring this
from a large number of patients manifesting Lyme arthritis, many whom
bear no other symptoms. Pachner considers serology an important tool,
but recognizes the test limitations: “...while the tests are
understandably unreliable for identification of patients with ECM...” he
explains that antibodies in some patients are not as high as in others,
associating a higher prevalence of antibodies in those with more
symptoms. He also states that those with only CNS disease, sometimes do
not have high titers.[7] This underscores the theory that some Lyme
patients can be seronegative but still have Lyme.
In an Italian paper from the same year, the topic of maternal/fetal
transmission of Lyme disease was discussed. From the abstract, we learn
that Lyme borreliosis acquired during pregnancy may be associated with
stillbirth and fetal malformations.[8]
By 1989 the understanding of Lyme disease is growing, and more
scientists are realizing the complexity of Lyme’s vast neurological
symptoms. In a Scottish article from the same year we read about a
“triad” of neurological symptoms of Lyme. “...meningoencephalitis,
cranial neuritis and peripheral neuritis is unique to the disease...”
But the list doesn’t stop there. The author describes the following
manifestations: “...pseudotumour cerebri, hemiparesis, demyelinating
disorders, optic atrophy, recurrent laryngeal nerve palsy and meningitis
so that Lyme disease must now be considered in the differential
diagnosis of a wide range of neurological disorders.”[9]
Two studies from 1993 examined the relationship between adverse
pregnancy outcomes and maternal exposure to Lyme disease. One study of
5,000 mothers with infants who participated in a cord blood serosurvey
showed that cardiac manifestations in the exposed infants were
significantly higher within the endemic group.[10] The other study
(Westchester County, NY) involved questionnaires to 2,000 women and
showed that “tick bites within 3 years preceeding conception were
significantly associated with congenital malformations.”[11]
In a 1994 letter to the editor of the Journal of Clinical Microbiology
regarding an article by Dr. Kenneth B. Liegner, we find a patient
treated for 5 days with oral doxycycline following tick removal. Three
months later the patient presented with fatigue and other symptoms. He
ignored these until progressive muscle hypotrophy, neurologic,
gastrointestinal, genitourinary and cardiorespiratory symptoms occurred.
27 months after tick bite, he was initially diagnosed with a psychiatric
disorder. 41 months following the bite, he was diagnosed by a
Neurologist as having “probable encephalomyelitis due to Bb.” This case
was included in the profile of patients with circulating immune
complexes to Bb and poor response to “standard” treatment for Lyme
disease. The letter points out the “unreliability of available
laboratory tests” and stresses the importance of clinical impressions
when patients are seronegative. The letter also describes a proactive
approach to prophylactic and therapeutic treatments, as in such cases
like the patient above which “could have been prevented.” The author’s
reply stated that European literature describing “progressive” borrelial
encephalomyelitis may be progressive because it was inadequately
treated. He further states that the lack of appreciation for the chronic
form of Lyme disease results in an “overreliance on treatment protocols
developed before a clear understanding of the pathobiology of the
infecting agent was possible. Now, with a clearer picture of
pathogenesis, physicians may offer prolonged treatment.”[12,13]
In a continuing education videotape from 1997 issued by the NCME, our
pretend Federation’s (IDSA member) Benjamin Luft (co-author of the
controversial IDSA Diagnostic and Treatment Guidelines) goes on film to
iterate the 1997 current IDSA beliefs about LD which include the
following, important statements:
| |
1. Lyme disease is a multi-systemic disease.
2. It is often difficult to diagnose.
3. Diagnoses are based on clinical findings, and not solely on
lab tests.
4. The presence or absence of infection should not be based
solely on a positive (+) or negative (-) test result.
5. Consideration should be given to the limitations of tests.
6. Lyme disseminates very quickly – within 2-4 weeks.
7. If left untreated, Lyme has a period of latency which can be
a period lasting years, only to become reexacerbated later in
life.
8. In 46 children followed by Steere et al. (NEJM
1991;325:159-163), none received treatment for at least 4 years
after tick bite.
39 patients were followed for 10-13 years, and most had
symptoms including arthralgias and neurological symptoms.
9. Testing in the early stages of LD may lead to false
negatives.
10. Immune response varies.
11. Antibiotics given early may reduce antibody production.
12. Serology may initially be negative, and if so, a 2nd serum
sample should be performed 4-6 weeks later where seroconversion
may be seen.
13. More sensitive and specific testing is needed.*
14. For severe cases of LD, the duration of treatment should be
based on severity of infection and the patient’s response to
treatment.
15. The causes of Lyme treatment failure were noted as (in part)
poor absorption to antibiotics, advanced illness (CNS Lyme), and
concomitant
tick-borne illnesses.[14]
|
*This information was taught to physicians during a time
period AFTER the 1994 Dearborn, MI diagnostic test criteria-establishing
conference which included IDSA members Steere, Barbour and associates –
criteria which are said to have been designed to facilitate the
emergence of the LYMErix vaccine (subsequently pulled from market);
criteria which are called “flawed” by Lyme-literate physicians, patients
and advocates because they are said to miss the majority of Lyme
patients; and criteria which are heavily promoted by the CDC and the
IDSA (and its guidelines), today.
We hold these (patent) truths to be self-evident
In (1988) U.S. patent #7,045,134 we read: “Current
technology enables correct diagnosis of certain infectious diseases only
after the disease has progressed to a certain maturity. By that time,
however, treatment is more difficult...”[15]
Patent #4,721,617, says: “The etiological agent of this disease is the
spirochete Borrelia burgdorferi, which is primarily transmitted by
Ixodes ticks...The spirochete has also been found in deerflies,
horseflies and mosquitos...” It goes on to describe: “…As many as
two-thirds of the people that become infected by this spirochete are
unaware of the tick bite because of the painless bite and the small size
(several mm) of the nymphal stage…The early phase of the illness often
consists of the ECM, headache, fatigue, muscle and joint aches, stiff
neck and chills and fever. This phase of the disease may be followed by
neurologic, joint or cardiac abnormalities…"
And we learn about the chronic form of LD and other issues from this
same patent: “…The chronic forms of the disease such as arthritis (joint
involvement), acrodermatitis chronica atrophicans (skin involvement),
and Bannwart's syndrome (neurological involvement) may last for months
to years and are associated with the persistence of the spirochete…"
And more alarming: "…A case of maternal-fetal transmission of B.
burgdorferi resulting in neonatal death has been reported……For every
symptomatic infection, there is at least one asymptomatic infection.
Lyme disease is presently the most commonly reported tick-borne disease
in the United States…”
Last, we learn about the effectiveness of treatment: "...The infection
may be treated at any time with antibiotics such as penicillin,
erythromycin, tetracycline, and ceftriaxone…Once infection has occurred,
however, the drugs may not purge the host of the spirochete but may only
act to control the chronic forms of the disease. Complications such as
arthritis and fatigue may continue for several years after diagnosis and
treatment…”[16]
So how is it that so much was known (and there are thousands of examples
over the few mentioned here), about Borrelia beginning decades ago, but
those facts have now become a “hot potato” of contention between
scientists, medical boards, government entities, treating physicians,
patients, and insurance companies? Why are the Infectious Disease
“stormtroopers” using the media to eradicate any mention of the truth
about Lyme disease which has been known for 3 decades, to re-spin it in
favor of minimalism?
Enter an era of self-interests, profit margins, pharmaceutical
interests, government-funded research, spin-off company ownership and
patent royalties held by the Federation members. This information at the
very least, is likely to come to light when the CT AG investigation is
completed. At best, time, publications and clinical studies will reveal
the truth around Lyme disease regarding its prevalence and persistence.
We find these relationships particularly interesting when we explore
Federation “members” like (IDSA member) Durland Fish’s involvement in
patents, research, and government-sponsored epidemiological studies
using satellite technologies to map vector-transmission, among other
things. The Federation of course would benefit from the censorship of
the civilian mindset regarding Lyme disease – because therein an
epidemic can be controlled and slow-played for maximum research dollars,
profits for insurance companies and pharmaceutical and diagnostic test
manufacturers. And many of the Federation members are paid spokespersons
for these entities, not to mention that they are patent-holders on the
technologies which are used for diagnostics and vaccines. But they won’t
necessarily tell you that, because disclosures and conflicts of interest
might bring their motivations under careful scrutiny – something the CT
AG may currently be pursuing.
Unfortunately for my imaginary Federation, the patients, advocates, and
their physicians who call themselves "Lyme-literate," are not going to
go away. They are going to continue to trumpet loudly that Lyme disease
in a chronic form exists, and that it must be acknowledged, and allowed
open-ended, individualized treatment. Although a few pioneering
physicians may be reprimanded for real or imagined "disobedience," the
number of Lyme-literate physicians opting off the managed care
merry-go-round will continue to increase as they answer the call of
their ill patients. These brave physicians will continue to train in
tick-borne illness diagnosis and treatment; which won't necessarily
include the ideology of the IDSA's impractical guidelines – because for
these physicians, patient care comes first over profits.
The number of academic, peer-reviewed articles proving the existence of
a persistent form of LD will also increase, as will the number of
patient cases with disability. Advocacy groups will not be silenced by a
handful of ID stormtroopers attempting to censor civilian mindset.
Unfortunately for the Federation, just as in Nazi Germany, their
“regime” may indeed be falling. We see evidence in the loud, defensive
protestation of subpoenas issued by the CT AG office; their
"astonishment" of an investigation of their guidelines; and their
increasing fears being revealed in their own publications. We witness
their desire to remain highly visible within the media in staunch
defense of self-serving guidelines and ideology; and most recently,
their strategic presence when a beloved Lyme physician is under fire,
and we see can see a transparent house of cards beginning to tumble.
Federation aside, in the end, within the world of Lyme disease, because
of the controversy, patients are not being treated, illness is going
unacknowledged, and the media is driven to distraction while innocent
people are suffering. We suggest as patients and advocates, that the
Federation go back to page 1, re-read their own previous research and
publications, and leave the book burning, virtual or not, to history.
References
1. Quote from Juan Ramon Jimenez, from Bradbury R. Fahrenheit 451.
Del Rey 1953.
2 Steere AC, Malawista SE, et al. Antibiotic Therapy in Lyme Disease.
Annals of Inter Med 1980:93(part 1):1-8.
3. Barbour AG, et al. Lyme Disease Spirochetes and Ixodid Tick
Spirochetes Share a Common Surface Antigenic Determinant Defined by a
Monoclonal Antibody. Infec and Immun. 1983 Aug;41(2):795-804.
4. Schmid GP, Steigerwalt AG, Johnson SE, Barbour AG, Steere AC, et al.
DNA Characterization of the Spirochete that causes Lyme disease. J Clin
Microbiol. 1984 Aug;20(2):155-158.
5. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme
disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology,
1985 Jan;35(1):47-53.
6. Pachner AR. Neurologic manifestations of Lyme disease, the new “great
imitator”. Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1482-6. [abstract]
7. Pachner AR. Borrelia burgdorferi in the nervous system: the new
“great imitator”. Annals of the NY Acad Sci. 1988;539(1):56-64. At:
www.annalsnyas.org/cgi/content/abstract/539/1/56. Accessed 2007 Jun 19.
8. Carlomagno G, et al. Lyme Borrelia positive serology associated with
spontaneous abortion in an endemic Italian area. Acta Eur Fertil. 1988
Sep-Oct;19(5):279-81.
9. Bourke SJ. Lyme disease. Biomed Pharmacother. 1989;43(6):397-400.
Glasgow Royal Infirmary, Scotland, UK. At: www.pubmed.gov. Accessed 2007
Jun 16.
10. Williams CL, et al. Maternal Lyme disease and congenital
malformations: a cord blood serosurvey in endemic and control areas.
Paediatr Perinat Epidemiol. 1995 Jul;9(3):320-30.
11. Strobino BA, et al. Lyme disease and pregnancy outcome: a
prospective study of two thousand prenatal patients. Am J Obstet Gynecol.
1993 Aug;169(2 Pt 1):367-74.
12. Lopez-Andreu, JA. Ferris J, et al. Treatment of Late Lyme Disease: A
Challenge to Accept. J Clin Microbiol. 1994. [Letters to Editor] Vol
32:1415-1416.
13. Liegner KB. Lyme disease: the sensible pursuit of answers. J. Clin
Microbiol. 1993;31:1961-1963.
14. Lyme Disease and Concomitant Tick-Borne Illnesses, NCME Continuing
Education Videotape, featuring Benjamin Luft. 60 min. 1997 June 27.
15. USPTO. US Patent 7,045,134. Qiu, et al. 1996 May 6. http://patft.uspto.gov.
Accessed 2007 Apr 7.
16. USPTO. US Patent 4,721,617. Johnson. 1988 Jan 26. http://patft.uspto.gov.
Accessed 2007 Apr 6.
PJ Langhoff is an author, advocate, lyme patient, mom of 2 lyme adults,
ordained minister and medical researcher.
She may be reached at pj@lymeleague.com
|